Isodiol International Inc said it is finalizing a private placement deal of up to $30 million. It will be led by existing backer Serruya Private Equity, which invests on behalf of Canada's Serruya family, and another institutional investor. Based in Vancouver, Isodiol is a developer and maker of raw ingredients and consumer products derived from cannabis. The funds raised will support the company's global growth and strategic initiatives. Isodiol, which this week announced an agreement to acquire Biosynthesis Pharma Group, a producer of industrial hemp, raised a $25 million financing from Alumnia Partners in August.